期刊文献+

N-乙酰-β-D-氨基葡萄糖苷酶同工酶等电聚焦测定及初步临床应用 被引量:1

暂未订购
导出
摘要 本文建立了一种测定N-乙酰-β-D-氨基葡萄糖苷酶(NAG)同工酶的管状聚丙烯酰胺凝胶等电聚焦分析法,胶浓度5%。pH 梯度3.5~10.结果表明,尿NAG-A 同工酶等电点为5.5,NAG-B为7.2.38例糖尿病患者尿液分析显示,糖尿病微血管病组NAG-B 活性显著高于无微血管病变组,NAG-B 活性对反映糖尿病性肾损害有一定价值.
出处 《临床检验杂志》 CAS CSCD 北大核心 1990年第2期61-63,共3页 Chinese Journal of Clinical Laboratory Science
  • 相关文献

同被引文献8

  • 1[5]Wolf G.New insights into the pathophysiology of diabetic nephropathy:from haemodynamics to molecular pathology[J].Eur J Clin Invest,2004,34:785.
  • 2[6]Schram MT,Chaturvedi N,Schalkwijk C,et al.Vascular risk factors and markers of endothelial function as determinants of inflammatory markers in type 1 diabetes[J].Diabetes Care,2003,26:2165.
  • 3[7]Tucker SM,Pierce RJ,Price RG.Charac1terisation of human N-scetyl-betaD-glucosaminidase isoenzymes as an indicator of tissue damage in disease[J].Clin Chim Acta,1980 Mar 14,102(1):29.
  • 4[8]Yuuki T,Kanda T,Kimura Y,et al.Inflammatory cytokines in vitreous fluid and serum of patients with diabetic vitreoretinopathy[J].J Diabetes Complicetions,2001,15:257.
  • 5[1]Martin DD,Davis EA,Jones TW.Acute effects of hyperglycaemia in children with type 1 diabetes mellitus:the patient's perspective[J].J Pediatr Endocrinol Metab,2006,19(7):927..
  • 6[2]Danne T,Kordonouri O,Enders I,et al.Monitoring for retionopathy in children and adolescents with type 1 diabetes[J].Acta Paediatr Suppl,1998,425:35.
  • 7[3]Yehong C,Seng Chia K.Markers of dabetic nephropathy.J Diabetes Comp[J],1998,12(1):43.
  • 8[4]Silink M.Global impact of diabetes[J].Pediatr Diabetes,2005;6(suppl3):32.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部